123 related articles for article (PubMed ID: 32242754)
1. Influences of different sugar ligands on targeted delivery of liposomes.
Zhang C; Chen Z; Li W; Liu X; Tang S; Jiang L; Li M; Peng H; Lian M
J Drug Target; 2020; 28(7-8):789-801. PubMed ID: 32242754
[TBL] [Abstract][Full Text] [Related]
2. Influences of galactose ligand on the uptake of TADF liposomes by HepG
Wang C; Chen Z; Tang X; Liu X; Na W; Li W; Liu T
Photodiagnosis Photodyn Ther; 2020 Dec; 32():102014. PubMed ID: 32950730
[TBL] [Abstract][Full Text] [Related]
3. Microfluidic synthesis of multifunctional liposomes for tumour targeting.
Ran R; Middelberg APJ; Zhao CX
Colloids Surf B Biointerfaces; 2016 Dec; 148():402-410. PubMed ID: 27639490
[TBL] [Abstract][Full Text] [Related]
4. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells.
Hu J; Wang J; Wang G; Yao Z; Dang X
Int J Mol Med; 2016 Mar; 37(3):690-702. PubMed ID: 26782731
[TBL] [Abstract][Full Text] [Related]
6. Mannosylated liposomes for targeted gene delivery.
Kong F; Zhou F; Ge L; Liu X; Wang Y
Int J Nanomedicine; 2012; 7():1079-89. PubMed ID: 22393297
[TBL] [Abstract][Full Text] [Related]
7. Effects of surface displayed targeting ligand GE11 on liposome distribution and extravasation in tumor.
Tang H; Chen X; Rui M; Sun W; Chen J; Peng J; Xu Y
Mol Pharm; 2014 Oct; 11(10):3242-50. PubMed ID: 25181533
[TBL] [Abstract][Full Text] [Related]
8. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors.
McNeeley KM; Karathanasis E; Annapragada AV; Bellamkonda RV
Biomaterials; 2009 Aug; 30(23-24):3986-95. PubMed ID: 19427688
[TBL] [Abstract][Full Text] [Related]
9. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
[TBL] [Abstract][Full Text] [Related]
10. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes.
Lin Q; Mao KL; Tian FR; Yang JJ; Chen PP; Xu J; Fan ZL; Zhao YP; Li WF; Zheng L; Zhao YZ; Lu CT
Cancer Chemother Pharmacol; 2016 Feb; 77(2):269-80. PubMed ID: 26666650
[TBL] [Abstract][Full Text] [Related]
11. Enhanced small interfering RNA delivery into cells by exploiting the additive effect between photo-sensitive peptides and targeting ligands.
Lin W; Xie X; Yang Y; Liu H; Fu X; Chen Y; Liu H; Yang Y
J Pharm Pharmacol; 2015 Sep; 67(9):1215-31. PubMed ID: 25880614
[TBL] [Abstract][Full Text] [Related]
12. Dual-ligand α
Levine RM; Kokkoli E
J Control Release; 2017 Apr; 251():24-36. PubMed ID: 28215671
[TBL] [Abstract][Full Text] [Related]
13. A photo-responsive peptide- and asparagine-glycine-arginine (NGR) peptide-mediated liposomal delivery system.
Xie X; Yang Y; Yang Y; Zhang H; Li Y; Mei X
Drug Deliv; 2016 Sep; 23(7):2445-2456. PubMed ID: 25693640
[TBL] [Abstract][Full Text] [Related]
14. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
16. Controlled targeting of liposomal doxorubicin via the folate receptor in vitro.
Saul JM; Annapragada A; Natarajan JV; Bellamkonda RV
J Control Release; 2003 Sep; 92(1-2):49-67. PubMed ID: 14499185
[TBL] [Abstract][Full Text] [Related]
17. Tuning Targeted Liposome Avidity to Cells via Lipid Phase Separation.
Vu TQ; Sant'Anna LE; Kamat NP
Biomacromolecules; 2023 Apr; 24(4):1574-1584. PubMed ID: 36943688
[TBL] [Abstract][Full Text] [Related]
18. Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells.
Li N; Fu T; Fei W; Han T; Gu X; Hou Y; Liu Y; Yang J
J Pharm Pharmacol; 2019 Aug; 71(8):1243-1254. PubMed ID: 31215039
[TBL] [Abstract][Full Text] [Related]
19. A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells.
Liu C; Liu XN; Wang GL; Hei Y; Meng S; Yang LF; Yuan L; Xie Y
Int J Nanomedicine; 2017; 12():2407-2425. PubMed ID: 28405164
[TBL] [Abstract][Full Text] [Related]
20. SREKA-targeted liposomes for highly metastatic breast cancer therapy.
Vári B; Dókus L; Borbély A; Gaál A; Vári-Mező D; Ranđelović I; Sólyom-Tisza A; Varga Z; Szoboszlai N; Mező G; Tóvári J
Drug Deliv; 2023 Dec; 30(1):2174210. PubMed ID: 36752075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
